Navigation Links
Phase 3 Data Show Bayer's Investigational Compound Regorafenib (BAY 73-4506) Met Primary Endpoint Showing Statistically Significant Improvement in Overall Survival in Patients with Metastatic Colorectal Cancer Refractory to Standard Approved Therapi
Date:1/17/2012

ntent/@epidemiologysurveilance/documents/document/acspc-028323.pdf. Accessed on October 24, 2011.

[iv] National Cancer Institute. Colon and Rectal Cancer. Available at: http://www.cancer.gov/cancertopics/types/colon-and-rectal. Accessed on October 24, 2011.

[v] National Cancer Institute. Stage IV and Recurrent Colon Cancer. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/colon/HealthProfessional/page9. Accessed on October 24, 2011.

[vi] S. Wilhelm, et al. Regorafenib (Bay 73-4506): A New Oral Multikinase Inhibitor of Angiogenic, Stromal, and Oncogenic Receptor Tyrosine Kinases with Potent Preclinical Antitumor Activity. Online International Journal of Cancer. December 17, 2010.

 

 


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Niiki Pharma Announces the Completion of Phase I Dose Escalation for First-in-Man Anti-Cancer Agent NKP-1339
2. Sangart Initiates Phase 1b Study of MP4CO in Patients With Sickle Cell Disease
3. Merrimack Pharmaceuticals Initiates Enrollment in Phase 1 Study of MM-151 in Patients with Refractory Advanced Solid Tumors
4. Suneva Medical to Pursue Expanded Indications for Artefill® With Launch of Phase III Acne Scar Study
5. Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI): Phase III Data on Bayers Investigational Compound Regorafenib (BAY 73-4506) in Patients with Metastatic Colorectal Cancer to be Presented as Late Breaking Or
6. Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
7. Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients
8. Pearl Therapeutics Announces Successful Completion of Phase 2b Safety and Efficacy Studies of COPD Combination, PT003
9. DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)
10. Pfizer Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences
11. ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  Regulatory affairs professionals ... where regulations are often strict and legislation is ... a demand for professionals who have a deep ... across a product lifecycle and demonstrate its use ... University of California, Irvine Extension , in partnership ...
(Date:8/31/2015)... 2015  Diplomat Pharmacy, Inc. (NYSE: DPLO ), the ... Hagerman , Chairman & CEO, and Sean Whelan , ... Mr. Hagerman and Mr. Whelan are scheduled to participate ... Boston on Wednesday, September 9, 2015 at 1:45 ... also scheduled to participate in the Robert W. Baird 2015 ...
(Date:8/31/2015)... Aug. 31, 2015  Qualcomm Incorporated (NASDAQ: ... Qualcomm Life, Inc., is collaborating with Davita ... management solutions powered by Qualcomm Life,s 2net™ Device ... enable continuous care, informed interventions and better management ... Qualcomm Life,s annual Connect 2015 ecosystem ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Diplomat to Participate in Upcoming Investor Conferences 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 2011 First Quarter Total Revenue $565 million, including $36 million ... growth for the combined company, excluding the impact of foreign exchange ... Diastat and Efudex, pro forma organic growth for the combined company ... EPS $0.02; Cash EPS $0.62 Excluding impact from ...
... 9, 2011 Medison and Samsung Electronics jointly announced ... company, a joint partnership between Korea,s leading diagnostic ultrasound ... most technologically-advanced electronics and consumer goods companies, has outlined ... leader in medical device industry. Mr. ...
Cached Medicine Technology:Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 2Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 3Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 4Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 5Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 6Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 7Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 8Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 9Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 10Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 11Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 12Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 13Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 14Samsung Medison Pledges to Become a World-Class Medical Device Company 2
(Date:8/31/2015)... ... August 31, 2015 , ... CareSource, ... and Corporate Communications. In this capacity, Michael will provide strategic leadership for CareSource’s ... leader in consumer-focused programs that have contributed to the company’s rapid growth. As ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... In an ... from the Plastic and Reconstructive Surgery Global Open Journal that discusses the future of ... article discussed how, in the future, customized implants, prosthetics, and other 3-D printed tools ...
(Date:8/31/2015)... ... , ... NJ Top Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and ... Michael Betsy graduated from Don Bosco Prep in 1990 and was Class Salutatorian. He ... sports in his senior year. He was inducted into the National Honor Society as ...
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... According ... of the University of Sweden showed that most adolescents who underwent bariatric surgery “felt ... average, the 88 adolescent bariatric patients who participated in the study felt that their ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dad Phil, son Scott, ... on Aug. 26, generously hosted by the Collinsville Chamber of Commerce, but the ... Call Center and website since Aug. 17. , The Greens have operated Green ...
Breaking Medicine News(10 mins):Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2
... those trying to lose weight, there is a lot of confusion ... now is // to eat a low carbohydrate diet, a new ... weight loss -- even when the amount of food is not ... 12-week low fat, high-carb diet alone and in combination with exercise. ...
... have Parkinson’s disease. It is a neurological condition // that ... therapy can improve both of these problems. A pulse of ... movement. This is done inorder to improve stiffness in patients. ... magnetic stimulation. ,For nearly 15 years, Criner has dealt ...
... shows the reason some adolescents experience depression could be ... to have a smaller hippocampus -- the part of ... ,Researchers sampled nearly 30 adolescents between ages 13 ... major depressive disorder.Magnetic resonance imaging was performed to measure ...
... most common type of plastic surgery performed for cosmetic ... 269,000 procedures were performed. ,Researchers examined data from ... the mammogram results of women with breast implants to ... of the study show breast implants decreased the sensitivity ...
... who suffer from migraine headaches may be at risk for ... brain where the tissue has died. ,Researchers studied ... grouped the patients into categories of having migraines with visual ... group was also included in the study. Participants had a ...
... bacterial infection that affects the gums and bones supporting ... can not only reveal the general health of patients ... ,Researchers from Japan studied more than 7,450 men and ... 37 items, including cholesterol and C-reactive protein, which are ...
Cached Medicine News:
... viscoelastic insert runs alongside the Achilles ... and targeted intermittent compression during movement. ... irritation of the Achilles tendon is ... wedge (raises heel about 6 mm). ...
... II is effective for acute, rehabilitation, ... to help prevent injury and reinjury ... exceptional support for medial and lateral ... plantar flexion. Unique split-pad system includes ...
Softsplint after bunion surgery. Hook-and-loop closure. Maintains hallux positioning and metatarsophalangeal alignment. Washable....
... Pediatric Ankle Cryo/Cuff is specifically designed to ... Using a combination of controlled compression and ... pain. The Pediatric Ankle Cryo/Cuff is ideal ... episodes in hemophilia.,The Pediatric Ankle Cryo/Cuff is ...
Medicine Products: